Form D — Mati Therapeutics Inc.
0001574251-25-000003 · filed Oct 8, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $10,523,695
- Reported amount sold
- $9,867,695
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Mati Therapeutics Inc.
- CIK
- 1574251
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 101 Colorado Street
AUSTIN, Texas 78701 - Phone
- 512-720-1333
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Butchofsky · Executive OfficerAustin, Texas Find on LinkedIn ↗
-
Christopher Muller · Executive OfficerAustin, Texas Find on LinkedIn ↗
-
Deepank Utkhede · DirectorAustin, Texas Find on LinkedIn ↗
-
Joseph Tortorice III · DirectorAustin, Texas Find on LinkedIn ↗
-
Cameron Nelson · Executive OfficerAustin, Texas Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗